Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6803525 | 1.00 | PGD (0.50) | PGDSLC22A6TSHRSMN1; SMN2MAPT | |
| SCHEMBL6805671 | 1.00 | PGD (0.50) | PGDSLC22A6TSHRSMN1; SMN2MAPT | |
| Ammonia Solution, Strong SCHEMBL27881579 | 0.97 | PGD (0.48) | PGDSLC22A6TSHRSMN1; SMN2MAPT | |
| SCHEMBL6448085 | 0.83 | ALDH1A1 (0.46) | PGDTSHRTDP1CYP2C19 | |
| SCHEMBL6448088 | 0.83 | ALDH1A1 (0.46) | PGDTSHRTDP1CYP2C19 | |
| SCHEMBL14962078 | 0.80 | SLC22A6 (0.52) | PGDSLC22A6TSHRSMN1; SMN2MAPT | |
| SCHEMBL3650683 | 0.79 | PGD (0.47) | PGDSLC22A6TSHRSMN1; SMN2MAPT | |
| SCHEMBL25660449 | 0.79 | PGD (0.47) | PGDSLC22A6SMN1; SMN2MAPTGABRR1 | |
| SCHEMBL6462796 | 0.77 | PGD (0.46) | PGDSLC22A6SMN1; SMN2MAPTGABRR1 | |
| SCHEMBL2467277 | 0.76 | TSHR (0.43) | PGDTSHRLMNATDP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630424-A1 | COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS | Third Harmonic Bio, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4592332-A1 | METHOD FOR PREPARING ALKYL POLY(3-HYDROXYPROPIONATE), ALKYL POLY(3-HYDROXYPROPIONATE), AND COMPOSITION COMPRISING SAME | LG CHEM, LTD. (KR) | 2025-07-30 | — | — | EP | disclosed |
| US-20250059157-A1 | TLR7/8 ANTAGONISTS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2025-02-20 | — | — | US | disclosed |
| CN-113728028-B | Compatible blends of terephthalate polyols and hydrocarbon blowing agents | 陶氏环球技术有限责任公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118434786-A | Imide-containing polyols, methods for preparing imide-containing polyols, and methods of using imide polyols | 陶氏环球技术有限责任公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240254119-A1 | COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS | Calixis Inc. | 2024-08-01 | — | — | US | disclosed |
| WO-2024124002-A1 | COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS | THIRD HARMONIC BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| US-20230303514-A1 | TLR7/8 ANTAGONISTS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2023-09-28 | — | — | US | disclosed |
| WO-2023092817-A1 | ADDITIVE FOR 193 NM DRY PHOTORESIST AND PREPARATION METHOD FOR AND APPLICATION OF ADDITIVE | 上海新阳半导体材料股份有限公司 | 2023-06-01 | — | — | WO | disclosed |
| US-11629134-B2 | TLR7/8 antagonists and uses thereof | MERCK PATENT GMBH (DE) | 2023-04-18 | — | — | US | disclosed |
| US-20120045398-A1 | Method For The Manufacture Of Nanoparticle Complexes And Triblock Polymer Ligands And Products Thereof | CENTRUM FUER ANGEWANDTE NANOTECHNOLOGIE GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
| EP-2403920-A2 | A METHOD FOR THE MANUFACTURE OF NANOPARTICLE COMPLEXES AND TRIBLOCK POLYMER LIGANDS AND PRODUCTS THEREOF | Centrum für Angewandte Nanotechnologie (CAN) GmbH (DE) | 2012-01-11 | — | — | EP | disclosed |
| US-20110105654-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-05-05 | — | — | US | disclosed |
| WO-2010100118-A2 | A METHOD FOR THE MANUFACTURE OF NANOPARTICLE COMPLEXES AND TRIBLOCK POLYMER LIGANDS AND PRODUCTS THEREOF | CENTRUM FÜR ANGEWANDTE NANOTECHNOLOGIE (CAN) GMBH (DE) | 2010-09-10 | — | — | WO | disclosed |
| US-20080051326-A1 | Antiinfective Lipopeptides | CUBIST PHARMACEUTICALS, INC. | 2008-02-28 | — | — | US | disclosed |
| US-6903233-B2 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1344763-A1 | Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters | Takasago International Corporation (JP) | 2003-09-17 | — | — | EP | disclosed |
| US-4725620-A | 2H-pyran-2,6-(3H)-dione derivatives with anti-allergic activity | ALLERGAN, INC. (US) | 1988-02-16 | — | — | US | disclosed |
| US-4288335-A | REACTING ESTER WITH PHOSPHORUS SULFIDE, METAL OXIDE | OROGIL (FR) | 1981-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | HDHD5, APEH, AOC3 | PGD 919/4885SLC22A6 1264/4885TSHR 302/4885 |
| US-20230303514-A1 | TLR7/8 ANTAGONISTS AND USES THEREOF | TLR7, TLR8, TLR9 | PGD 4547/4885SLC22A6 2628/4885TSHR 791/4885 |
| US-11629134-B2 | TLR7/8 antagonists and uses thereof | TLR7, TLR8, TLR9 | PGD 4547/4885SLC22A6 2628/4885TSHR 791/4885 |
| US-20240254119-A1 | COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS | KIT, AURKC, PRKCE | PGD 3089/4885SLC22A6 3622/4885TSHR 4660/4885 |
| US-20080051326-A1 | Antiinfective Lipopeptides | VIP, NGLY1, PREP | PGD 2705/4885SLC22A6 3518/4885TSHR 4050/4885 |
| US-20110105654-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | GNMT, PAM, SMOX | PGD 215/4885SLC22A6 3385/4885TSHR 1761/4885 |
| US-20250059157-A1 | TLR7/8 ANTAGONISTS AND USES THEREOF | TLR7, TLR8, TLR9 | PGD 4547/4885SLC22A6 2628/4885TSHR 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.